Science Studies

Gut Wealth® supplements are based of gut-boosting ingredients and a postbiotic ingredient, all designed to support your digestive wellbeing.

Studies show the benefits of our beneficial bacteria

Our beneficial bacteria is a safe, stable and easy-to-use that offers benefits including:

Helps regular bowel movement and digestive comfort ¹
May contribute to gut wellbeing ²
Helps to regulate immunity ³
Stimulates natural defences ³
Calms down digestive upset ⁴
Supports & improves digestive health ^{5, 6}
Resolves the symptoms and reduces the duration of diarrhoea significantly ^{5, 7}

Studies on our key ingredient

Numbers related to benefits listed above

1- Xiao SD, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60

2-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591.

3-Oral Probiotics Reduce Incidence of Necrotizing Enterocolitis and Sepsis in Neonates with Hypoxic Ischemic Encephalopathy.

3-Elfrargy et al. 2014 Journal of American Science

4-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591.

5- Liévin-Le Moal V, et al. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea. Pediatrics. 2007;120(4):e795-803.

6-Multicenter, Randomized, Controlled Trial of Heat-Killed Lactobacillus acidophilus LB in Patients with Chronic Diarrhea.

6-Xiao et al. 2003. Advances in Therapy

7-Salazar-Lindo E. et al. Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children. JPGN. 2007; 44:571-576

Medtech & Healthtech StartUp of the Year 2024🏆

Science Studies

Studies show the benefits of our beneficial bacteria

Studies on our key ingredient

Numbers related to benefits listed above

1- Xiao SD, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60

2-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591.

3-Oral Probiotics Reduce Incidence of Necrotizing Enterocolitis and Sepsis in Neonates with Hypoxic Ischemic Encephalopathy.

3-Elfrargy et al. 2014 Journal of American Science

4-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591.

5- Liévin-Le Moal V, et al. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea. Pediatrics. 2007;120(4):e795-803.

6-Multicenter, Randomized, Controlled Trial of Heat-Killed Lactobacillus acidophilus LB in Patients with Chronic Diarrhea.

6-Xiao et al. 2003. Advances in Therapy

7-Salazar-Lindo E. et al. Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children. JPGN. 2007; 44:571-576

Your cart -

Medtech & Healthtech StartUp of the Year 2024🏆

Main Menu

Science Studies

Studies show the benefits of our beneficial bacteria

Studies on our key ingredient

Numbers related to benefits listed above

1- Xiao SD, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60​

2-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591. ​

3-Oral Probiotics Reduce Incidence of Necrotizing Enterocolitis and Sepsis in Neonates with Hypoxic Ischemic Encephalopathy. ​

3-Elfrargy et al. 2014 Journal of American Science​

4-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591. ​

5- Liévin-Le Moal V, et al. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea. Pediatrics. 2007;120(4):e795-803.​

6-Multicenter, Randomized, Controlled Trial of Heat-Killed Lactobacillus acidophilus LB in Patients with Chronic Diarrhea.​

6-Xiao et al. 2003. Advances in Therapy​

7-Salazar-Lindo E. et al. Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children. JPGN. 2007; 44:571-576​

Your cart -

1- Xiao SD, et al. Multicenter, randomized, controlled trial of heat-killed Lactobacillus acidophilus LB in patients with chronic diarrhea. Adv Ther. 2003;20(5):253-60

2-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591.

3-Oral Probiotics Reduce Incidence of Necrotizing Enterocolitis and Sepsis in Neonates with Hypoxic Ischemic Encephalopathy.

3-Elfrargy et al. 2014 Journal of American Science

4-Tarrerias et al. The effect of inactivated Lactobacillus LB fermented culture medium on symptom severity: observational investigation in 297 patients with diarrhea-predominant irritable bowel syndrome. Dig Dis. 2011;29(6):588–591.

5- Liévin-Le Moal V, et al. An experimental study and a randomized, double-blind, placebo-controlled clinical trial to evaluate the antisecretory activity of Lactobacillus acidophilus strain LB against nonrotavirus diarrhea. Pediatrics. 2007;120(4):e795-803.

6-Multicenter, Randomized, Controlled Trial of Heat-Killed Lactobacillus acidophilus LB in Patients with Chronic Diarrhea.

6-Xiao et al. 2003. Advances in Therapy

7-Salazar-Lindo E. et al. Effectiveness and safety of Lactobacillus LB in the treatment of mild acute diarrhea in children. JPGN. 2007; 44:571-576